🇺🇸 FDA
Patent

US 7972606

T24 antigen for immunodiagnosis of Taenia solium cysticercosis

granted A61KA61K38/00A61K39/00

Quick answer

US patent 7972606 (T24 antigen for immunodiagnosis of Taenia solium cysticercosis) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/00, A61K39/00